STOCK TITAN

Vita Coco CFO exercises options, sells 3,000 shares

Vita Coco Company, Inc.'s Chief Financial Officer Corey Baker reported a sequence of option exercises and stock sales.

(High)
(Negative)
Form Type
4

Rhea-AI Filing Summary

Vita Coco Company, Inc.'s Chief Financial Officer Corey Baker reported a sequence of option exercises and stock sales. He exercised Non-Qualified Stock Options for 2,000 shares of Common Stock at an exercise price of $16.9100 per share, then sold 3,000 Common Stock shares at prices of $38.6600 and $40.0000 per share pursuant to a Rule 10b5-1 trading plan. Following these transactions, he directly holds 38,754 shares of Common Stock and 59,197 Non-Qualified Stock Options.

Positive

  • None.

Negative

  • None.

Insights

TL;DR: Routine insider sales under a Rule 10b5-1 plan plus option holdings; transactions primarily reflect planned trading and option vesting schedules.

The Form 4 indicates that the CFO executed multiple sell and buy transactions in common stock on 09/11/2025, 09/12/2025 and 09/15/2025, including sales reported as effected pursuant to a Rule 10b5-1 trading plan. Reported purchases at $16.91 and sales near $40.00 changed beneficial ownership between 38,754 and 39,754 shares. The filing also itemizes non-qualified stock options with exercise prices of $16.91, $24.35, $26.18, $27.59 and $33.36 and various vesting schedules and expirations through 03/04/2035. For investors, these are disclosure of insider liquidity and ongoing equity incentives rather than an operational update.

TL;DR: Disclosures follow standard governance practices; sales were executed under a Rule 10b5-1 plan and multiple option grants include staggered vesting.

The Form 4 provides clear disclosure of planned share sales under a Rule 10b5-1 trading plan and detailed option vesting terms, including multi-year vesting schedules and exercisable amounts. The filing is transparent about the nature of indirect ownership and vesting timelines, which supports standard insider trading compliance and equity compensation governance. No amendments or corrective notes are present in the filing text provided.

Insider BAKER COREY
Role Chief Financial Officer
Sold 3,000 shs ($119K)
Approx. gross sale proceeds $119K
Approx. exercise cost $34K
Type Security Shares Price Value
Exercise Non-Qualified Stock Option (right to buy) 1,000 $0.00 $0.00
Exercise Common Stock 1,000 $16.91 $17K
Sale Common Stock 1,000 $40.00 $40K
Exercise Non-Qualified Stock Option (right to buy) 1,000 $0.00 $0.00
Exercise Common Stock 1,000 $16.91 $17K
Sale Common Stock 1,000 $40.00 $40K
Sale Common Stock 1,000 $38.66 $39K
holding Non-Qualified Stock Option (right to buy) -- -- --
holding Non-Qualified Stock Option (right to buy) -- -- --
holding Non-Qualified Stock Option (right to buy) -- -- --
holding Non-Qualified Stock Option (right to buy) -- -- --
Holdings After Transaction: Non-Qualified Stock Option (right to buy) — 59,197 contracts for 46,992 underlying shares (Direct); Common Stock — 38,754 shares (Direct)
Footnotes (5)
  1. F1. The sales of shares of common stock reported were effected pursuant to a Rule 10b5-1 trading plan.
  2. F2. The stock option vests in four equal annual installments beginning on March 10, 2024.
  3. F3. The stock option is vested as to 40% and will vest the remaining 30% on March 10, 2025, 20% on March 10, 2026 and 10% on March 10, 2027.
  4. F4. The stock option vests in four equal annual installments beginning on March 4, 2025.
  5. F5. The Reporting Person was granted stock options that will vest in four annual equal installments on each anniversary of the grant date provided that the Reporting Person remains in continuous service on each vesting date.
Shares sold 3,000 shares Total Common Stock sold across reported transactions (transactionSummary sellShares)
Shares acquired via option exercise 2,000 shares Common Stock obtained by exercising Non-Qualified Stock Options at $16.9100 per share
Option exercise price (exercised) $16.9100 per share Strike price for Non-Qualified Stock Options exercised on September 12 and 15, 2025
Post-transaction Common Stock holding 38,754 shares Direct Common Stock position reported after the transactions
Post-transaction option holding 59,197 options Direct Non-Qualified Stock Option holding reported after the transactions
Remaining option exercise price 1 $24.3500 per share Exercise price for a remaining Non-Qualified Stock Option grant expiring 2033-05-10
Remaining option exercise price 2 $33.3600 per share Exercise price for a remaining Non-Qualified Stock Option grant expiring 2035-03-04
Rule 10b5-1 trading plan regulatory
"sales of shares of common stock reported were effected pursuant to a Rule 10b5-1 trading plan"
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
Non-Qualified Stock Option financial
"Non-Qualified Stock Option (right to buy)"
A non-qualified stock option (NSO) is a contract that lets an employee or service provider buy company shares at a fixed price for a set period, like a voucher to purchase stock later at today’s price. It matters to investors because exercising NSOs creates ordinary income for the holder and can increase share count, affecting a company’s earnings and ownership mix; think of it as a future sale that can dilute existing shareholders and has immediate tax consequences for the recipient.
vests in four equal annual installments financial
"The stock option vests in four equal annual installments beginning on March 10, 2024."
continuous service financial
"provided that the Reporting Person remains in continuous service on each vesting date."

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What trades did Vita Coco (COCO) CFO Corey Baker report on this Form 4?

Corey Baker reported option exercises for 2,000 shares and sales of 3,000 Common Stock shares. The exercised options had a strike price of $16.9100 per share, and the sales occurred at $38.6600 and $40.0000 per share under a Rule 10b5-1 trading plan.

How many Vita Coco (COCO) shares and options does Corey Baker hold after these transactions?

After the reported trades, Corey Baker directly holds 38,754 shares of Common Stock and 59,197 Non-Qualified Stock Options. These post-transaction holdings are reported as his canonical positions in Common Stock and Non-Qualified Stock Options.

Did Corey Baker’s sales of Vita Coco (COCO) stock occur under a Rule 10b5-1 plan?

Yes. The filing states that the reported sales of Common Stock were effected pursuant to a Rule 10b5-1 trading plan. Such plans pre-arrange trades, which can reduce the informational significance of the exact timing of these sales.

What option exercises did Vita Coco (COCO) CFO Corey Baker complete in this filing?

Baker exercised Non-Qualified Stock Options covering 2,000 shares of Common Stock at an exercise price of $16.9100 per share. These exercises were reported on September 12 and 15, 2025, each for 1,000 underlying shares.

What remaining stock option grants are shown for Corey Baker at Vita Coco (COCO)?

The filing lists several remaining Non-Qualified Stock Option positions with exercise prices of $24.3500, $26.1800, $27.5900 and $33.3600 per share. Their underlying share amounts range from 8,746 to 13,481 shares, with expirations between 2033 and 2035.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
BAKER COREY

(Last) (First) (Middle)
250 PARK AVE SOUTH
SEVENTH FLOOR

(Street)
NEW YORK NY 10003

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Vita Coco Company, Inc. [ COCO ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Financial Officer
3. Date of Earliest Transaction (Month/Day/Year)
09/11/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 09/11/2025 S(1) 1,000 D $38.66 38,754 D
Common Stock 09/12/2025 M 1,000 A $16.91 39,754 D
Common Stock 09/12/2025 S(1) 1,000 D $40 38,754 D
Common Stock 09/15/2025 M 1,000 A $16.91 39,754 D
Common Stock 09/15/2025 S(1) 1,000 D $40 38,754 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Non-Qualified Stock Option (right to buy) $16.91 09/12/2025 M 1,000 (2) 03/10/2033 Common Stock 1,000 $0.0 13,205 D
Non-Qualified Stock Option (right to buy) $16.91 09/15/2025 M 1,000 (2) 03/10/2033 Common Stock 1,000 $0.0 12,205 D
Non-Qualified Stock Option (right to buy) $24.35 (3) 05/10/2033 Common Stock 13,481 13,481 D
Non-Qualified Stock Option (right to buy) $26.18 (4) 03/04/2034 Common Stock 8,746 8,746 D
Non-Qualified Stock Option (right to buy) $27.59 (3) 08/07/2033 Common Stock 11,547 11,547 D
Non-Qualified Stock Option (right to buy) $33.36 (5) 03/04/2035 Common Stock 13,218 13,218 D
Explanation of Responses:
1. The sales of shares of common stock reported were effected pursuant to a Rule 10b5-1 trading plan.
2. The stock option vests in four equal annual installments beginning on March 10, 2024.
3. The stock option is vested as to 40% and will vest the remaining 30% on March 10, 2025, 20% on March 10, 2026 and 10% on March 10, 2027.
4. The stock option vests in four equal annual installments beginning on March 4, 2025.
5. The Reporting Person was granted stock options that will vest in four annual equal installments on each anniversary of the grant date provided that the Reporting Person remains in continuous service on each vesting date.
By: Alison Klein, Attorney-in-Fact For: Corey Baker 09/15/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Keep reading